Dr. Samir S. Taneja

Dr. Taneja is the James M. and Janet Riha Neissa Professor of Urologic Oncology and Vice-Chair of Urology at NYU Grossman School of Medicine. He directs both the Division of Urologic Oncology and the Smilow Comprehensive Prostate Cancer Center, where multiparametric MRI (mpMRI), PSMA-PET, and whole-genome sequencing set the framework for every treatment decision. Multidisciplinary boards integrate these data with patient-reported goals, producing individualised pathways that prioritise oncologic control alongside preservation of continence and sexual function.

 

A pioneer of MRI–ultrasound fusion biopsy, Dr. Taneja led prospective trials demonstrating that targeted cores double the detection of clinically significant prostate cancer while avoiding over-diagnosis of indolent disease. His team refined the Hood, Tunnel, and NeuroSAFE nerve-sparing techniques, documented in over ten-thousand robotic prostatectomies, and reported positive-margin rates below ten percent with continence recovery that outperforms published benchmarks. Ongoing work explores real-time fluorescence to map cavernous nerves and ctDNA clearance as an early surrogate for biochemical recurrence. 

 

Beyond the operating theatre, he maintains a translational laboratory that interrogates androgen-receptor splice variants and metabolic rewiring after focal therapy. Collaborations with NYU Tandon’s Biomedical Engineering department and Cold Spring Harbor Laboratory support this bench-to-bedside agenda, underscoring a career that links technical innovation with mechanistic discovery.